Literature DB >> 10996345

The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.

M F Lopes-Virella1, S Koskinen, M Mironova, D Horne, R Klein, C Chassereau, C Enockson, G Virella.   

Abstract

In the present study we try to define the optimal conditions for preparation of copper-oxidized low-density lipoprotein (oxLDL) to be used for the assay of oxLDL antibodies by enzyme immunoassay (EIA). Oxidation of LDL was monitored by measuring the formation of conjugated dienes at 234 nm and the generation of fluorescent products with emission at 430 nm when excitation is performed at 360 nm. The generation of immunogenic epitopes was evaluated by testing the reactivity of aliquots collected at different times during the oxidation process with human sera with high oxLDL antibody levels and with a purified human oxLDL antibody. The values of fluorescence emission at 430 nm correlated best with reactivity with oxLDL antibodies; strong reactivity was usually associated with values greater than 1.1 U. The time needed for fluorescence emission to reach maximum levels varied between 6 and 14 h for most LDL, but it was considerably longer in a few LDL preparations. The maximal reactivity of oxLDL with oxLDL antibodies was observed when the LDL oxidation reaction was stopped 4 or more hours after the fluorescence readings reached their peak. At this stage of the oxidation reaction, apolipoprotein B fragmentation and aggregation were observed as shown by Western blot analysis. The CV for 13 EIA runs of two reference oxLDL antibodies reacting with four different pools of standardized oxLDL prepared according to the stated guidelines was 14.5 and 3.9%, confirming the reproducibility of our oxidation conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996345     DOI: 10.1016/s0021-9150(99)00456-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Lipoprotein autoantibodies: measurement and significance.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages.

Authors:  Kent J Smith; Waleed O Twal; Farzan Soodavar; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

3.  Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.

Authors:  Gabriel Virella; Rickey E Carter; Antonio Saad; Edward G Crosswell; B Andrew Game; Maria F Lopes-Virella
Journal:  Clin Immunol       Date:  2008-06       Impact factor: 3.969

4.  Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.

Authors:  Samar M Hammad; Waleed O Twal; Jeremy L Barth; Kent J Smith; Antonio F Saad; Gabriel Virella; W Scott Argraves; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-05-28       Impact factor: 5.162

5.  Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.

Authors:  Lakshmi Narasimha Rao; Thiruvelselvan Ponnusamy; Sheena Philip; Rupak Mukhopadhyay; Vijay V Kakkar; Lakshmi Mundkur
Journal:  Lipids       Date:  2015-07-16       Impact factor: 1.880

6.  Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release.

Authors:  Jean-Philip Truman; Mohammed M Al Gadban; Kent J Smith; Russell W Jenkins; Nalini Mayroo; Gabriel Virella; Maria F Lopes-Virella; Alicja Bielawska; Yusuf A Hannun; Samar M Hammad
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

7.  Development of capture assays for different modifications of human low-density lipoprotein.

Authors:  Gabriel Virella; M Brooks Derrick; Virginia Pate; Charlyne Chassereau; Suzanne R Thorpe; Maria F Lopes-Virella
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

8.  Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress.

Authors:  Mohammed M Al Gadban; Kent J Smith; Farzan Soodavar; Christabelle Piansay; Charlyne Chassereau; Waleed O Twal; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella; Samar M Hammad
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

9.  Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.

Authors:  Kasey C Vickers; Colin T Maguire; Robert Wolfert; Alan R Burns; Michael Reardon; Richard Geis; Paul Holvoet; Joel D Morrisett
Journal:  J Lipid Res       Date:  2009-04-09       Impact factor: 5.922

10.  Effect of immunization against ox-LDL with two different antigens on formation and development of atherosclerosis.

Authors:  Sedigheh Asgary; Salb-Ali Saberi; Shirin Azampanah
Journal:  Lipids Health Dis       Date:  2007-11-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.